Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China.
Dai, Zonglin; Wong, Irene O L; Xie, Chan; Xu, Wenxiong; Xiang, Yu; Peng, Liang; Lau, Eric H Y.
Afiliação
  • Dai Z; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region of China.
  • Wong IOL; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region of China.
  • Xie C; Department of Infectious Disease, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Xu W; Department of Infectious Disease, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Xiang Y; Division of Epidemiology, School of Public Health, Fudan University, Shanghai, China.
  • Peng L; Department of Infectious Disease, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Electronic address: pliang@mail.sysu.edu.cn.
  • Lau EHY; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region of China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong Special Administrative Region of China. Electronic address: ehylau
Clin Microbiol Infect ; 28(2): 300.e1-300.e8, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34197929

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite B Crônica Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite B Crônica Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article